2023 ICD-10-CM Diagnosis Code Q50.31

Accessory ovary

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx POA Exempt
  • Q50.31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM Q50.31 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of Q50.31 - other international versions of ICD-10 Q50.31 may differ.
ICD-10-CM Coding Rules
  • Q50.31 is applicable to female patients.
The following code(s) above Q50.31 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to Q50.31:
  • Q00-Q99
    2023 ICD-10-CM Range Q00-Q99

    Congenital malformations, deformations and chromosomal abnormalities

    Note
    • Codes from this chapter are not for use on maternal records
    Type 2 Excludes
    • inborn errors of metabolism (E70-E88)
    Congenital malformations, deformations and chromosomal abnormalities
  • Q50-Q56
    2023 ICD-10-CM Range Q50-Q56

    Congenital malformations of genital organs

    Type 1 Excludes
    • androgen insensitivity syndrome (E34.5-)
    • syndromes associated with anomalies in the number and form of chromosomes (Q90-Q99)
    Congenital malformations of genital organs
Present On Admission
POA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
  • Q50.31 is considered exempt from POA reporting.
ICD-10-CM Q50.31 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 742 Uterine and adnexa procedures for non-malignancy with cc/mcc
  • 743 Uterine and adnexa procedures for non-malignancy without cc/mcc
  • 760 Menstrual and other female reproductive system disorders with cc/mcc
  • 761 Menstrual and other female reproductive system disorders without cc/mcc

Convert Q50.31 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to Q50.31:

ICD-10-CM Codes Adjacent To Q50.31
Q45.3 Other congenital malformations of pancreas and pancreatic duct
Q45.8 Other specified congenital malformations of digestive system
Q45.9 Congenital malformation of digestive system, unspecified
Q50 Congenital malformations of ovaries, fallopian tubes and broad ligaments
Q50.0 Congenital absence of ovary
Q50.01 …… unilateral
Q50.02 …… bilateral
Q50.1 Developmental ovarian cyst
Q50.2 Congenital torsion of ovary
Q50.3 Other congenital malformations of ovary
Q50.31 Accessory ovary
Q50.32 Ovarian streak
Q50.39 Other congenital malformation of ovary
Q50.4 Embryonic cyst of fallopian tube
Q50.5 Embryonic cyst of broad ligament
Q50.6 Other congenital malformations of fallopian tube and broad ligament
Q51 Congenital malformations of uterus and cervix
Q51.0 Agenesis and aplasia of uterus
Q51.1 Doubling of uterus with doubling of cervix and vagina
Q51.10 …… without obstruction
Q51.11 …… with obstruction

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.